Agarwal Arjun

Senior Vice President, FinanceOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$687K
Net Open-Market Flow
-$687K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)395$69.69$28K17K
Jun 12, 2026Option exercise(M)1K$34.39$50K27K
Jun 12, 2026Sell(S)2K$68.34$127K25K
Jun 12, 2026Sell(S)4K$69.85$303K21K
Jun 12, 2026Sell(S)3K$70.34$229K17K
Jun 12, 2026Option exercise(M)8K$12.50$100K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 12, 2026Option exercise(M)8K$0110K
Jun 12, 2026Option exercise(M)1K$063K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000064) within minutes of acceptance. Every field above traces to the original document. Verify it directly: